Literature DB >> 2745263

Rapid HPLC assay of fluoroquinolones in clinical specimens.

C Y Chan1, A W Lam, G L French.   

Abstract

A simple isocratic HPLC procedure was developed for the analysis of seven quinolones and their metabolites in clinical specimens. It is likely that this system can be used for the assay of many other quinolone compounds, but not for nalidixic acid and the ciprofloxacin metabolite sulpho-ciprofloxacin which appear to be adsorbed in the column. Sample preparation takes approximately 20 min, and HPLC analysis is completed within 15 min with a simple solvent system eluted on a reversed phase column. The procedure is rapid, sensitive and specific, and is a modification of an assay for chloramphenicol and beta-lactam antibiotics. This method is therefore particularly useful for clinical laboratories, since a single HPLC system can be used for assays of chloramphenicol, beta-lactams and quinolones.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2745263     DOI: 10.1093/jac/23.4.597

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  7 in total

1.  Determination of temafloxacin, sarafloxacin, and difloxacin in bulk drug and dosage forms by high-performance liquid chromatography.

Authors:  J F Bauer; L Elrod; J R Fornnarino; D E Heathcote; S K Krogh; C L Linton; B J Norris; J E Quick
Journal:  Pharm Res       Date:  1990-11       Impact factor: 4.200

Review 2.  Lomefloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  A N Wadworth; K L Goa
Journal:  Drugs       Date:  1991-12       Impact factor: 9.546

Review 3.  Ofloxacin. A reappraisal of its antimicrobial activity, pharmacology and therapeutic use.

Authors:  P A Todd; D Faulds
Journal:  Drugs       Date:  1991-11       Impact factor: 9.546

4.  The pharmacokinetics of oral fleroxacin and ciprofloxacin in plasma and sputum during acute and chronic dosing.

Authors:  E J Begg; R A Robson; D A Saunders; G G Graham; R C Buttimore; A M Neill; G I Town
Journal:  Br J Clin Pharmacol       Date:  2000-01       Impact factor: 4.335

5.  An in vitro study on the compatibility and precipitation of a combination of ciprofloxacin and vancomycin in human vitreous.

Authors:  M Hui; A K H Kwok; C P Pang; S W Cheung; R C Y Chan; D S C Lam; A F B Cheng
Journal:  Br J Ophthalmol       Date:  2004-02       Impact factor: 4.638

6.  Ofloxacin penetration into tuberculous pleural effusion.

Authors:  W W Yew; J Lee; C Y Chan; S W Cheung; P C Wong; S Y Kwan
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

7.  Determination of ciprofloxacin in human plasma using high-performance liquid chromatography coupled with fluorescence detection: application to a population pharmacokinetics study in children with severe malnutrition.

Authors:  Simon N Muchohi; Nahashon Thuo; Japhet Karisa; Alex Muturi; Gilbert O Kokwaro; Kathryn Maitland
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2010-12-04       Impact factor: 3.205

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.